サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016215)
◆英語タイトル:Cyclin-Dependent Kinases (CDKs) Inhibitors -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016215
◆発行日:2018年11月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるサイクリン依存性キナーゼ阻害剤のパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・サイクリン依存性キナーゼ阻害剤の概要
・サイクリン依存性キナーゼ阻害剤のパイプライン概要
・企業別開発中のサイクリン依存性キナーゼ阻害剤
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・サイクリン依存性キナーゼ阻害剤の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・サイクリン依存性キナーゼ阻害剤開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Cyclin-Dependent Kinases (CDKs) Inhibitors-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Cyclin-Dependent Kinases (CDKs) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cyclin-Dependent Kinases (CDKs) Inhibitors. DelveInsight’s Report also assesses the Cyclin-Dependent Kinases (CDKs) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Cyclin-Dependent Kinases (CDKs) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Cyclin-Dependent Kinases (CDKs) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Cyclin-Dependent Kinases (CDKs) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Cyclin-Dependent Kinases (CDKs) Inhibitors Overview
• Cyclin-Dependent Kinases (CDKs) Inhibitors Disease Associated
• Cyclin-Dependent Kinases (CDKs) Inhibitors Pipeline Therapeutics
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics under Development by Companies
• Cyclin-Dependent Kinases (CDKs) Inhibitors Filed and Phase III Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Phase II Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Phase I and IND Filed Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Discontinued Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Cyclin-Dependent Kinases (CDKs) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Monotherapy Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Combination Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics – Discontinued Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Monotherapy Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Combination Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Molecule Type


*** レポートのキーワード ***

サイクリン依存性キナーゼ阻害剤、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • マイクロファブリッククーラーバッグの世界市場
    Micro Fabric Cooler Bag Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States …
  • NHCC – Jinja Low Income Housing – Uganda:建設プロジェクト概要
    World Market Intelligence's "NHCC – Jinja Low Income Housing – Uganda - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the NHCC – Jinja Low Income Housing – Uganda construction project. World Market Intelligence's "NHCC …
  • 香料(香水)製品市場動向:アメリカ
    Product Synopsis This report provides a concise overview of the Fragrances market in the US. After reading this report, you will understand the size of the market, and the economic, demographic, and behavioral trends that will drive its evolution, and the leading players within the market, allowing …
  • Mobiletop Co., Ltd.:企業SWOT分析(IT・通信業界)
    Summary This comprehensive SWOT profile of Mobiletop Co., Ltd. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats …
  • 個人用防護具 (PPE) の配布の世界及び中国市場 2018年
    The 'Global and Chinese Personal Protective Equipment (PPE) Distribution Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Personal Protective Equipment (PPE) Distribution industry with a focus on the Chinese market. The report provid …
  • Cubist Pharmaceuticals, Inc. (CBST)(製薬・医療分野):企業のM&A・提携動向
    Summary Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company. It researches, develops and commercializes therapeutic products addressing unmet medical needs in the acute care environment. The company’s lead product, Cubicin (daptomycin for injection) is used to treat complicated skin …
  • モバイルWiMAXの世界市場:戦略的事業レポート
    This report analyzes the worldwide markets for Mobile WiMAX in number of Subscribers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. …
  • 武器運送・放出システムの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Weapons Carriage & Release System is the system to store and release weapons using for fast jets, rotorcraft and Unmanned Aerial Vehicles. Weapons Carriage and Release products may include a range of missile launchers, bomb racks, ejection launchers, etc. Scope of the Report: This report focuses on …
  • 世界の無酸素銅市場2017
    Oxygen-Free Copper Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Ger …
  • インドのエチルベンゼン市場(~2019):市場規模、シェア、動向
    Ethylbenzene Industry Outlook in India to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalData’s new report, "Ethylbenzene Industry Outlook in India to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016215 )"サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018" (英文:Cyclin-Dependent Kinases (CDKs) Inhibitors -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。